Our department carries out comprehensive tumor treatment such as tumor chemotherapy and biotherapy, and is the master’s degree granting site of Shandong University in oncology and the refresher base for primary tumor doctors, with one chief physician, one deputy chief physician, two master’s degree supervisors and two doctoral degree holders. Director Li Yan is the director of Shandong Biomedical Engineering Society Biotargeted Therapy Committee and the deputy director of Shandong Anti-Cancer Association Chemotherapy Committee. The team is characterized by good learning and innovation, and good service attitude, which is praised by the majority of patients. Our department gives tumor patients preoperative and postoperative chemotherapy, radical chemotherapy, palliative chemotherapy, nutritional support and end-of-life care, and carries out individualized comprehensive tumor treatment in strict accordance with NCCN (National Cancer Network) chemotherapy guidelines. Biological therapy improves patients’ immune function, serves as consolidation and maintenance therapy after radical treatment, prevents tumor recurrence and metastasis, and improves the quality of life of patients with advanced disease. The department has many clinical pharmacists to guide medical care and patients to standardize medication. Li Yan, Department of Oncology Chemotherapy, Shandong Qianfo Mountain Hospital
Specialties
1. Rich clinical experience in the prevention, diagnosis, treatment and complication management of malignant tumors. Emphasis on comprehensive tumor treatment: preoperative chemotherapy, postoperative chemotherapy, radical chemotherapy, palliative chemotherapy, nutritional support and end-of-life care for patients with advanced malignant tumors, etc. with high efficiency.
2. Biological therapy for malignant tumors: passive immunity: cytokine-mediated killer cells (CIK); active immunity: dendritic cell anti-tumor vaccine (DC).
3. The joint testing of serum tumor-related substances is an effective means of screening healthy people, monitoring high-risk people and observing tumor patients.
4.In addition to the traditional intravenous chemotherapy, the research and application of multi-channel and hourly chemotherapy has been carried out, which has achieved better tumor treatment effect.
5. In the process of tumor treatment, we strictly abide by the principles of standardization, synthesis, individualization and objectivity.
(1) Standardization: the formulation of chemotherapy protocols applies internationally and nationally recognized effective protocols.
(2) Integration: to adopt comprehensive treatment according to the patient’s tumor pathology, disease duration, physical condition and other factors to achieve the best treatment effect.
(3) Individualization: according to the patient’s individual condition, determine the best plan and drug dose for that patient to maximize the therapeutic efficacy and reduce toxic side effects.
(4) Objective: to evaluate the effect of tumor treatment by using objective and clear imaging means.